Loading company
Latest annual · FY2025
Millions- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q2 FY2026
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Accustem Sciences Inc. (ACUT) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.8 million | -$1.5 million | 10-K 2026-04-14 · proof | |
| Net income | -$1.8 million | -$1.5 million | 10-K 2026-04-14 · proof | |
| Cash from operating activities | -$850,389 | -$664,066 | 10-K 2026-04-14 · proof | |
| Total assets | $1.5 million | $50,851 | +2,947% | 10-K 2026-04-14 · proof |
| Total liabilities | $5 million | $3.4 million | +47.2% | 10-K 2026-04-14 · proof |
| Cash and cash equivalents | $13,929 | $5,046 | +176% | 10-K 2026-04-14 · proof |
- What was Accustem Sciences Inc. (ACUT)'s operating income in fiscal 2025?
- Accustem Sciences Inc. (ACUT) reported operating income of -$1.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Apr 14, 2026. SEC
- What was Accustem Sciences Inc. (ACUT)'s net income in fiscal 2025?
- Accustem Sciences Inc. (ACUT) reported net income of -$1.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Apr 14, 2026. SEC
- What was Accustem Sciences Inc. (ACUT)'s cash from operating activities in fiscal 2025?
- Accustem Sciences Inc. (ACUT) reported cash from operating activities of -$850,389 for fiscal 2025 (the year ended Dec 31, 2025), against -$664,066 the year before. Source: the 10-K filed with the SEC on Apr 14, 2026. SEC
- What are Accustem Sciences Inc. (ACUT)'s total assets?
- As of Dec 31, 2025, Accustem Sciences Inc. (ACUT) reported total assets of $1.5 million, against $50,851 a year earlier (+2,947%). Source: the 10-K filed with the SEC on Apr 14, 2026. SEC
- What are Accustem Sciences Inc. (ACUT)'s total liabilities?
- As of Dec 31, 2025, Accustem Sciences Inc. (ACUT) reported total liabilities of $5 million, against $3.4 million a year earlier (+47.2%). Source: the 10-K filed with the SEC on Apr 14, 2026. SEC
- What are Accustem Sciences Inc. (ACUT)'s cash and cash equivalents?
- As of Dec 31, 2025, Accustem Sciences Inc. (ACUT) reported cash and cash equivalents of $13,929, against $5,046 a year earlier (+176%). Source: the 10-K filed with the SEC on Apr 14, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:ACUT&period_type=annual&limit=5"Information only, not investment advice.